RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02179 RECBIO-B

Closed 08-29 15:31:01

7.740

-0.140

-1.78%

High7.740	Low7.740	Vol1.00K
Open7.740	D1 Closing7.880	Amplitude0.00%
Mkt Cap3.74B	Tradable Cap2.45B	Total Shares482.96M
T/O7.74K	T/O Rate0.00%	Tradable Shares316.14M
P/B6.46	ROE-70.23%	EPS-1.27
52wk High9.800	52wk Low6.760	P/E-6.07
Dividend0.00	Div.Yield0.00	ROA-17.32%

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"02179","market":"HK","secType":"STK","nameCN":"RECBIO-B","latestPrice":7.74,"timestamp":1756452661188,"preClose":7.88,"halted":0,"volume":1000,"delay":0,"floatShares":316138689,"shares":482963000,"eps":-1.274533834885842,"marketStatus":"Closed","change":-0.14,"latestTime":"08-29 15:31:01","open":7.74,"high":7.74,"low":7.74,"amount":7740,"amplitude":0,"askPrice":7.9,"askSize":3000,"bidPrice":7.74,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.274533834885842,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1756690200000},"marketStatusCode":5,"adr":0,"listingDate":1648656000000,"exchange":"SEHK","adjPreClose":7.88,"openAndCloseTimeList":[[1756431000000,1756440000000],[1756443600000,1756454400000]],"volumeRatio":0.020121,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02179","defaultTab":"news","newsList":[{"id":"1111196582","title":"RECBIO-B (02179) Reports Interim Results with Shareholders' Attributable Loss of 341 Million Yuan, Up 36.7% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1111196582","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111196582?lang=en_us&edition=full_marsco","pubTime":"2025-08-29 19:24","pubTimestamp":1756466665,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) announced its interim results for 2025, reporting continuing operations revenue of 10.899 million yuan (RMB, same below), compared to nil in the same period last year. Loss...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2563044089","title":"Jiangsu Recbio Technology H1 Capex RMB 55.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2563044089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563044089?lang=en_us&edition=full_marsco","pubTime":"2025-08-29 19:02","pubTimestamp":1756465338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nPLX98822E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2553773217","title":"Jiangsu Recbio Technology Co. Ltd. Awaits Regulatory Approval for Domestic Share Issuance Amidst Uncertainties","url":"https://stock-news.laohu8.com/highlight/detail?id=2553773217","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553773217?lang=en_us&edition=full_marsco","pubTime":"2025-07-23 19:42","pubTimestamp":1753270958,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. has announced that it has received a reply from the China Securities Regulatory Commission  regarding the issuance of domestic shares. The regulatory approval is part of an ongoing review process, and the issuance is contingent upon the fulfillment of certain conditions outlined in previous announcements and circulars. Jiangsu Recbio Technology is committed to keeping its shareholders and potential investors informed about the progress of this issuance in compliance with the Inside Information Provisions and Listing Rules. As of now, there is no indication that the grant or funding involves multiple organizations; it appears to be solely related to Jiangsu Recbio Technology Co., Ltd.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDLT6VMh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2547067317","title":"Jiangsu Recbio Technology Enters Partnership with India's Biological E for HPV 9-Valent Vaccine Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2547067317","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547067317?lang=en_us&edition=full_marsco","pubTime":"2025-06-30 17:47","pubTimestamp":1751276879,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co. Ltd. has announced a new partnership with India's Biological E Company to collaborate on the recombinant HPV 9-valent vaccine REC603. Under this agreement, Jiangsu Recbio will provide Biological E with the vaccine formulation, filling, and packaging technologies, and will later extend the drug substance production technology. Biological E has been granted exclusive rights to develop, manufacture, and commercialize the vaccine in India and markets led by UNICEF and PAHO. The partnership includes upfront and milestone payments, along with royalties based on annual net sales.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL5jmqmG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2544612580","title":"Jiangsu Recbio Technology Co. Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2544612580","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544612580?lang=en_us&edition=full_marsco","pubTime":"2025-06-20 18:03","pubTimestamp":1750413817,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co. Ltd. held its annual general meeting on June 20, 2025. During the meeting, the proposal for the appointment of Mr. CHEN Gang as a board observer was approved. Additionally, the amendments to the Articles of Association were considered and approved, with the amended articles set to become effective upon the proposed changes in the company's business scope taking effect.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief on June 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDLbSHDtH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2537493479","title":"Jiangsu Recbio Technology's Board Green Lights H Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2537493479","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537493479?lang=en_us&edition=full_marsco","pubTime":"2025-05-22 20:40","pubTimestamp":1747917634,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology's (HKG:2179) board approved the proposed conversion of 141,953,490 unlisted shares into H shares, a Wednesday Hong Kong bourse filing said.Conversion will take place after th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2537986996","title":"Jiangsu Recbio Technology Co. Ltd. Board Meeting: Participation in H Share Full Circulation Plan and Election of Ms. Chen Qingqing to Nomination Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2537986996","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537986996?lang=en_us&edition=full_marsco","pubTime":"2025-05-21 17:46","pubTimestamp":1747820792,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co. Ltd. Board Meeting: Participation in H Share Full Circulation Plan and Election of Ms. Chen Qingqing to Nomination Committee. Jiangsu Recbio Technology Co. Ltd. recently held a board meeting where several key resolutions were passed. Among the decisions made, Ms. Chen Qingqing was elected as a member of the nomination committee for the Board's second session. The Board also approved proposed changes to the company's business scope and amendments to the Articles of Association. Additionally, the company announced its proposed participation in the H Share Full Circulation Plan, in alignment with the guidelines issued by the China Securities Regulatory Commission. A circular detailing these changes and a notice for the upcoming general meeting will be published soon.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL23x5VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":-0.0296},{"period":"3month","weight":-0.0773},{"period":"6month","weight":-0.0718},{"period":"1year","weight":-0.0675},{"period":"ytd","weight":-0.1705}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0206},{"period":"3month","weight":0.0734},{"period":"6month","weight":0.0897},{"period":"1year","weight":0.413},{"period":"ytd","weight":0.2462}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.071825},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.044398},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.06484},{"month":4,"riseRate":0.25,"avgChangeRate":-0.083572},{"month":5,"riseRate":0.25,"avgChangeRate":-0.027385},{"month":6,"riseRate":0.25,"avgChangeRate":-0.013774},{"month":7,"riseRate":0.5,"avgChangeRate":-0.016314},{"month":8,"riseRate":0.25,"avgChangeRate":-0.029617},{"month":9,"riseRate":0.333333,"avgChangeRate":0.008675},{"month":10,"riseRate":0.666667,"avgChangeRate":0.045462},{"month":11,"riseRate":0,"avgChangeRate":-0.122778},{"month":12,"riseRate":1,"avgChangeRate":0.175091}],"exchange":"SEHK","name":"RECBIO-B","nameEN":"RECBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest RECBIO-B(02179) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"RECBIO-B,02179,RECBIO-B股票,RECBIO-B股票老虎,RECBIO-B股票老虎国际,RECBIO-B行情,RECBIO-B股票行情,RECBIO-B股价,RECBIO-B股市,RECBIO-B股票价格,RECBIO-B股票交易,RECBIO-B股票购买,RECBIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest RECBIO-B(02179) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}